ArticleACS omega2024
Osteoinduction and Osteoconduction Evaluation of Biodegradable Magnesium Alloy Scaffolds in Repairing Large Segmental Defects in Long Bones of Rabbit Models.
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnesium (Mg) alloy scaffolds demonstrate promising potential for clinical applications in the repair of segmental bone defects. However, the specific mechanisms of osteoconduction and osteoinduction facilitated by these scaffolds themselves during the bone reconstruction process remain inadequately defined. This investigation systematically assesses the properties of MAO-coated Mg base implants both in vitro and in vivo. Furthermore, it elucidates the correlation between scaffold characteristics and bone regeneration in the repair of extensive long-bone defects, measuring up to 20 mm, without the use of additional bone graft materials. Electrochemical measurements and immersion tests conducted in vitro indicate that the MAO coating substantially enhances the corrosion resistance of the underlying Mg alloy. Meanwhile, the application of MAO coatings has been shown to significantly improve cytocompatibility, cellular adhesion, and osteogenic differentiation, as evidenced by the CCK-8 assays, ALP activity measurements, Western blot, and RT-qPCR in vitro. At 24 weeks postimplantation with the MAO-coated Mg alloy scaffold, the large segmental defects were effectively repaired concerning both integrity and continuity. The Micro-CT gradual replacement of old bone with new bone on the implant surface was observed by X-ray and Micro-CT. Meanwhile, the histological results indicated that the MAO-coated Mg alloy scaffold maintained a robust osteogenic response. In summary, the MAO-coated Mg alloy scaffold independently exhibits effective osteoconduction and osteoinduction, playing a significant role in bone repair function without the need for additional bone graft materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.